摘要
雌激素受体(ER)在乳腺癌的发生和发展中起重要作用,抗雌激素治疗的内分泌治疗为重要的治疗方案,但易产生三苯氧胺(TAM)的耐药性而使治疗失效,原因之一可能是由于表皮生长因子受体(EGFR)和HER-2高表达引起ER磷酸化所致。本文概述了其中的分子机制和可能涉及的传导通路等。
Estrogen receptor(ER) plays important roles in progression of breast cancer, anti-estrogen is majors therapeutic method for breast cancer, but acquired resistance to tamoxifen in breast cancer patients is a serious problem, and the over expression of EGFR, HER-2 leading to phosphorylation of ER may be a major reason. The mechanism of molecular and related pathway of transduction was chiefly elucidated in this article.
出处
《生物技术通讯》
CAS
2006年第6期939-941,共3页
Letters in Biotechnology